PMMA Bone Cements Market Seen Reaching $1.73 Billion by 2030

The global polymethyl methacrylate bone cements market is projected to grow from $1.34 billion in 2026 to $1.73 billion by 2030, driven by more orthopedic procedures, sports injuries, and demand for faster recovery options. North America led the market in 2025, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - PMMA bone cements are used to anchor implants and fill bone gaps in orthopedic surgery, making the market directly tied to joint replacement, fracture repair and other bone procedures. - The market’s projected rise signals higher demand for surgical materials that support implant stability and recovery as orthopedic care expands. - Rising sports-related injuries add another layer of demand for orthopedic treatments that use PMMA bone cement.

What happened: - The Business Research Company said the PMMA bone cements market will increase from $1.25 billion in 2025 to $1.34 billion in 2026. - The report projects the market will reach $1.73 billion by 2030. - The forecast covers market size, trends and growth through 2035. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The details: - Historical growth was linked to an aging global population, more orthopedic surgeries, rising osteoarthritis cases, improved hospital infrastructure and greater need for implant stability in bone repair. - Forecast growth is expected to come from minimally invasive surgical techniques, more sports-related injuries, more ambulatory surgery centers, demand for quicker recovery and innovations in bone cement formulations. - The report points to more joint replacement surgeries, higher demand for high-viscosity cements, broader use in vertebral repair, more trauma surgery use and improved handling properties as emerging trends. - The National Safety Council reported an 8% increase in exercise and exercise equipment-related injuries in 2023, rising from 445,642 in 2022 to 482,886 in 2023. - PMMA bone cement is a synthetic material used in orthopedic operations to secure implants and fill bone defects. - Its biocompatibility makes it a common choice in joint replacement procedures where reliable fixation is important. - The market analysis spans Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report’s 2026 package includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables. - More information is available in the full report and a free sample.

Between the lines: - The forecast suggests PMMA bone cements remain a steady, procedure-driven market rather than a consumer-facing one. - Injury trends and aging demographics point to sustained demand, but growth still depends on surgery volumes and hospital adoption of newer techniques. - The fastest growth in Asia-Pacific suggests surgical capacity and healthcare access are becoming more important to the market than simple maturity in North America.

What's next: - Growth is likely to track changes in orthopedic procedure volumes, especially joint replacement, trauma repair and vertebral repair. - Product development will likely focus on handling, viscosity and formulation improvements that fit minimally invasive and faster-recovery procedures. - Regional gains in Asia-Pacific could narrow the gap with North America if surgery access and ambulatory care continue to expand.

The bottom line: - PMMA bone cements are on a path of moderate but durable expansion, with orthopedic demand and injury rates keeping the market on a steady climb.